Angle (United Kingdom) is Biotechnology in United Kingdom that focus on Parsortix technology business. Founded in 1994. They cover business area such as ANGLE PLC, pioneer product, cancer diagnostic, its patented Parsortix technology, (Circulating Tumor Cells)CTCs, patient blood, its geographical segment, Europe, North America.
1994
( 30 years old in 2024 )
Parsortix Technology
-
10 Nugent Road
Surrey Research Park
Guildford GU2 7AF
England, United Kingdom
Private
ANGLE PLCpioneer productcancer diagnosticits patented Parsortix technology(Circulating Tumor Cells)CTCspatient bloodits geographical segmentEuropeNorth America
* We use standard office opening hours in near Angle (United Kingdom)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Angle (United Kingdom) is Biotechnology business from United Kingdom that founded in 1994 (30 years old in 2024), Angle (United Kingdom) business is focusing on Parsortix Technology.
Angle (United Kingdom) headquarter office and corporate office address is located in 10 Nugent Road Surrey Research Park Guildford GU2 7AF England, United Kingdom.
Angle (United Kingdom) was founded in United Kingdom.
In 2024, Angle (United Kingdom) is currently focus on Parsortix technology sector.
Above is snippet of Google Trends for "Parsortix technology" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Angle (United Kingdom), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
